Baker Bros. Advisors LP Y M Abs Therapeutics, Inc. Transaction History

Baker Bros. Advisors LP

  • $9.34 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$14.39 - $35.8 $1.99 Million - $4.96 Million
-138,514 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$23.81 - $33.78 $850,350 - $1.21 Million
35,714 Added 34.74%
138,514 $4.33 Million
Q4 2018

Feb 13, 2019
SELL
$15.41 - $28.92 $727,352 - $1.37 Million
-47,200 Reduced 31.47%
102,800 $2.09 Million
Q3 2018

Nov 14, 2018
BUY
$24.0 - $26.97 $3.6 Million - $4.05 Million
150,000 New
150,000 $3.98 Million

Others Institutions Holding YMAB

# of Institutions
106
Shares Held
24.5M
Call Options Held
40.3K
Put Options Held
400
View Full List

About Y-mAbs Therapeutics, Inc.

YMAB Quotes by TradingView
  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $355M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track Baker Bros. Advisors LP Portfolio

Follow Baker Bros. Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email